Clinical Trials Directory

Trials / Conditions / MALT Lymphoma

MALT Lymphoma

12 registered clinical trials studyying MALT Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMolecular and Cellular Characterization of MALT Lymphoma
NCT07376330
International Extranodal Lymphoma Study Group (IELSG)—
RecruitingStudy of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
Schrödinger, Inc.Phase 1
UnknownPSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
NCT05003141
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)Phase 1
Active Not RecruitingPhase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma
NCT01808599
International Extranodal Lymphoma Study Group (IELSG)Phase 2
CompletedEndomicroscopy and Gastric MALT-lymphoma
NCT01583699
Medical University of ViennaN/A
UnknownTrial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type
NCT00923663
Medical University of ViennaPhase 2
CompletedTrial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lympho
NCT01015248
Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaPhase 2
CompletedCombination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Ritux
NCT00783367
Abramson Cancer Center at Penn MedicinePhase 2
CompletedThalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients
NCT00373646
Medical University of ViennaPhase 2
CompletedFludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
NCT00117156
Dana-Farber Cancer InstitutePhase 2
CompletedEradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of
NCT00201422
National Health Research Institutes, TaiwanN/A
CompletedVelcade in MALT Lymphoma Patients
NCT00373906
Medical University of ViennaPhase 2